This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.
Diabetic medicine : a journal of the British Diabetic Association, 21(11), 1204-12
Citation
Ratner, R E; Dickey, R; Fineman, M; Maggs, D G; Shen, L; Strobel, S A; Weyer, C; Kolterman, O G. (2004). Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.. Diabetic medicine : a journal of the British Diabetic Association, 21(11), 1204-12.